Sven Andréasson - Search on European Projects Archive

Ideas
Partners
Consultants
Calls
EU Projects
Blog NEW
- Europe towards City Innovation Hubs
  
  Written by Matteo Satta EU funding has always helped cities support their innovation processes, particularly on digital transformation and environment, but the approach is now moving toward a new ambitious […]
- Mistakes that Cities Should Be Avoiding in EU Projects
  
  By Matteo Satta Nowadays, we are seeing an increasing trend of people requesting to lower taxes and, as a result, public budgets. This leads many cities to try to find […]
- How a city can boost your Smart City project
  
  By Matteo Satta The commission has been heavily investing in pilot Smart City projects for a long time, but you may often have R&D or innovation projects pretending to have […]
- How to involve a city in your project? Here are a few tips.
  
  Article written by Matteo Satta (Smart) City projects are more and more funded by the European Commission, but consortia often struggle to get cities on board or really engage them. […]
- >> See all posts
Log In Sign Up

2 European Projects Found

Searched on 125080 European Projects

FINISHED

Beta Cell Therapy in Diabetes (BETACELLTHERAPY)

Start date: Jan 1, 2010, End date: Jun 30, 2015,

Type 1 diabetes is a serious chronic disease with major health risks and heavy burden on patients and society. It is caused by massive immune-mediated loss of insulin-producing beta cells in the pancreas that can so far not be locally corrected. A cellular allotransplant in the liver can install a new beta cell mass but the size is insufficient and the procedure faces limitations of donor shortage ...

Read Project

18

Partners Participants Partners

FINISHED

Corline Heparin Technology - Enabling Regenerative Medicine (Corline)

Start date: Apr 1, 2011, End date: Sep 30, 2013,

Regenerative Medicine (use of cells and tissue to replace or heal impaired functions in the body, RM) is one of the fastest growing areas in today’s medicine, and has the potential to offer treatment to patients with diseases that are currently untreatable. In many new areas of RM there is however a need to improve the outcome of RM concepts and technologies for it to become a viable option to tra ...

Read Project